https://www.coltonconsortium.org/directory/yael-haberman-md-phd/
Professor, Sheba Medical Center, Tel Aviv UniversityGray Faculty of Medical and Health Sciences Dr. Yael Haberman is a clinician-scientist and Associate Professor at the Gray Faculty of Medical and Health […]
https://www.coltonconsortium.org/directory/ken-cadwell-phd/
T. Grier Miller Professor of Medicine, Department of Medicine, Perelman School of Medicine, University of Pennsylvania Dr. Ken Cadwell is the T. Grier Miller Professor of Medicine at the Perelman […]
https://www.coltonconsortium.org/directory/manolis-roulis-phd/
Assistant Professor, Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania Dr. Manolis Roulis is Assistant Professor of Pathology and Laboratory Medicine at the Perelman School […]
https://www.coltonconsortium.org/directory/hajera-amatullah-phd/
Assistant Professor, Department of Systems Pharmacology and Translational Therapeutics, Perelman School of Medicine, University of Pennsylvania Dr. Hajera Amatullah is an Assistant Professor of Systems Pharmacology and Translational Therapeutics at […]
https://www.coltonconsortium.org/directory/stefan-feske-md/
Vice Chair for Research, Department of Pathology, NYU Grossman School of Medicine / NYU Langone Health Jeffrey Bergstein Professor of Medicine, Department of Pathology, NYU Grossman School of Medicine / NYU […]
https://www.coltonconsortium.org/projects/spatial-dynamics-of-intestinal-b-cell-immunoreceptor-signaling-in-health-and-disease-ibd/
Using single-molecule imaging to visualize B cell receptor signaling across gut compartments, this project uncovers how intestinal B cell education breaks down in IBD, revealing new targets for therapeutic intervention.
https://www.coltonconsortium.org/projects/the-role-of-glycosylation-in-inflammatory-bowel-disease/
Investigating how foreign sugar modifications on anti-TNF biologics trigger immune responses in pediatric IBD patients, this project aims to personalize biologic therapy selection and inform safer drug design.
https://www.coltonconsortium.org/projects/a-data-driven-framework-for-predicting-and-managing-flares-in-inflammatory-bowel-disease/
Combining machine learning with microbiome and metabolomic data from 4,000+ IBD patients, this project develops tools to predict disease flares, identify therapeutic targets, and enable personalized flare prevention.
https://www.coltonconsortium.org/publications/microbiome-research-in-autoimmune-and-immune-mediated-inflammatory-diseases-lessons-advances-and-unmet-needs/
https://www.coltonconsortium.org/publications/differences-in-disease-characteristics-and-treatment-exposures-between-paediatric-and-adult-onset-inflammatory-bowel-disease-using-a-registry-based-cohort/